Abstract
Human immunodeficiency virus (HIV) is a member of the retro virus family, classified under the lentivirus genus. Retroviruses are enveloped RNA viruses, which contain a core of capsid proteins, viral RNA, and enzymes. All infectious retroviral virions contain an enzyme, reverse transcriptase, which catalyzes the formation of a complementary DNA strand from an RNA template. A double-stranded DNA copy of the viral RNA genome (proviral DNA) may then be integrated into and replicated with the host cell genome.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Dalgleish A. G., Beverley P. C., Clapham P. R., Crawford D. H., Greaves M. F., and Weiss R. A. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763–767.
Simmons G., Wilkinson D., Reeves J. D., Dittmar M. T., Beddows S., Weber J., et al. (1996) Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70, 8355–8360.
Tersmette M., de Goede R. E., Al B. J., Winkel I. N., Gruters R. A., Cuypers H. T., et al. (1988) Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62, 2026–2032.
Walker C. M., Moody D. J., Stites D. P., and Levy J. A. (1986) CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563–1566.
Cocchi F., DeVico A. L., Garzino Demo A., Arya S. K., Gallo R. C., and Lusso P. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811–1815.
Feng Y., Broder C. C., Kennedy P. E., and Berger E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872–877.
Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667–673.
Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661–666.
Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., and Berger E. A. (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955–1958.
Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., et al. (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135–1148.
Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., et al. (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149–1158.
Deng H. K., Unutmaz D., KewalRamani V. N., and Littman D. R. (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296–300.
Farzan M., Choe H., Martin K., Marcon L., Hofmann W., Karlsson G., et al. (1997) Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186, 405–411.
Liao F., Alkhatib G., Peden K. W., Sharma G., Berger E. A., and Farber J. M. (1997) STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185, 2015–2023.
Reeves J. D., McKnight A., Potempa S., Simmons G., Gray P. W., Power C. A., et al. (1997) CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 231, 130–134.
Loetscher M., Amara A., Oberlin E., Brass E., Legler D. F., Loetscher P., et al. (1997) TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr. Biol. 7, 652–660.
Horuk R., Hesselgesser R., Zhou Y., Faulds D., Halks-Miller M., Harvey S., et al. (1998) The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J. Biol. Chem. 273, 386–391.
McKnight A., Wilkinson D., Simmons G., Talbot S., Picard L., Ahuja M., et al. (1997) Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71, 1692–1696.
Connor R. I., Sheridan K. E., Ceradini D., Choe S., and Landau N. R. (1997) Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185, 621–628.
Rucker J., Edinger A. L., Sharron M., Lee B., Berson J. F., Yi Y., et al. (1997) Utilization of chemokine receptors, orphan receptors, and herpes virus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71, 8999–9007.
Berger E. A., Doms R. W., Fenyo E.-M., Korber B. T. M., Littman D. R., Moore J. P., et al. (1998) A new classification for HIV-1. Nature 391, 240.
Detels R., Liu Z., Hennessey K., Kan J., Visscher B. R., Taylor J. M., et al. (1994) Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 7, 1263–1269.
Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367–377.
Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856–1862.
Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C. M., et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722–725.
Winkler C., Modi W., Smith M. W., Nelson G. W., Wu X., Carrington M., et al. (1998) Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene Variant. Science 279, 389–393.
Simmons G., Clapham P. R., Picard L., Offord R. E., Rosenkilde M. M., Schwartz T. W., et al. (1997) Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276, 276–279.
Mack M., Luckow B., Nelson P. J., Cihak J., Simmons G., Clapham P. R., et al. (1998) Aminooxypentane-RANTES induces CCR5 internalization but inhibts recycling: A novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187, 1215–1224.
Connor R. I., Paxton W. A., Sheridan K. E., and Koup R. A. (1996) Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1. J. Virol. 70, 8758–8764.
Oravecz T., Pall M., Wang J., Roderiquez G., Ditto M., and Norcross M. A. (1997) Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J. Immunol. 159, 4587–4592.
Doranz B. J., Grovit Ferbas K., Sharron M. P., Mao S. H., Goetz M. B., Daar E. S., et al. (1997) A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186, 1395–1400.
Donzella G. A., Schols D., Lin S. W., Este J. A., Nagashima K. A., Maddon P. J., et al. (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 4, 72–77.
Schols D., Este J. A., Henson G., and De Clercq E. (1997) Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. Antiviral Res. 35, 147–156.
Murakami T., Nakajima T., Koyanagi Y., Tachibana K., Fujii N., Tamamura H., et al. (1997) A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J. Exp. Med. 186, 1389–1393.
Bleul C. C., Wu L., Hoxie J. A., Springer T. A., and Mackay C. R. (1997) The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925–1930.
Sallusto F., Mackay C. R., and Lanzavecchia A. (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277, 2005–2007.
He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., et al. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645–649.
Kledal T. N., Rosenkilde M. M., Coulin F., Simmons G., Johnsen A. H., Alouani S., et al. (1997) A broad-spectrum chemokine antagonist encoded by Kaposi§ sarcoma-associated herpesvirus. Science 277, 1656–1659.
Boshoff C., Endo Y., Collins P. D., Takeuchi Y., Reeves J. D., Schweickart V. L., et al. (1997) Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290–294.
Tersmette M., Koot M., De Goede R. E. Y., Kootstra N., and Schuitemaker H. (1995) Isolation and biological characterization of primary HIV-1 isolates, in HIV: A Practical Approach (Karn J., ed.), vol. 1, Oxford University Press Oxford, UK, pp. 47–61.
Pal R., Garzino Demo A., Markham P. D., Burns J., Brown M., Gallo R. C., and DeVico A. L. (1997) Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 278, 695–698.
Kimpton J. and Emerman M. (1992) Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66, 2232–2239.
Bron R., Klasse P. J., Wilkinson D., Clapham P. R., Pelchen Matthews A., Power C., et al. (1997) Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. J. Virol. 71, 8405–8415.
Moore J. P., McKeating J. A., Weiss R. A., and Sattentau Q. J. (1990) Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139–1142.
Collins M., Montaner L. J., Herbein G., and Gordon S. (1995) HIV infection of macrophages, in: HIV: A Practical Approach (Karn J., ed.), vol. 1, Oxford University Press Oxford, UK, pp. 63–76.
Hinkula J., Rosen J., Sundqvist V. A., Stigbrand T., and Wahren B. (1990) Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol. Immunol. 27, 395–403.
McKnight A., Clapham P. R., and Schulz T. F. (1995) Detection of HIV entry into cells, in: HIV: A Practical Approach (Karn J., ed.), vol. 1, Oxford University Press Oxford, UK, pp. 129–141.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Reeves, J.D., Simmons, G. (2000). Chemokine Inhibition of HIV Infection. In: Proudfoot, A.E.I., Wells, T.N.C., Power, C.A. (eds) Chemokine Protocols. Methods in Molecular Biology, vol 138. Humana Press. https://doi.org/10.1385/1-59259-058-6:209
Download citation
DOI: https://doi.org/10.1385/1-59259-058-6:209
Publisher Name: Humana Press
Print ISBN: 978-0-89603-722-9
Online ISBN: 978-1-59259-058-2
eBook Packages: Springer Protocols